FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034307554> ?p ?o ?g. }

• W2034307554 endingPage "251" @default.
• W2034307554 startingPage "247" @default.
• W2034307554 abstract "The prognosis for thalassemia major has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop progressive accumulation of iron. This can lead to tissue damage and eventually death, particularly from cardiac disease. Previous studies that investigated iron chelation treatments, including retrospective and prospective non-randomised clinical trials, suggested that mortality, due mainly to cardiac damage, was reduced or completely absent in patients treated with deferiprone (DFP) alone or a combined deferiprone–deferoxamine (DFP–DFO) chelation treatment. However, no survival analysis has been reported for a long-term randomised control trial. Here, we performed a multicenter, long-term, randomised control trial that compared deferoxamine (DFO) versus DFP alone, sequential DFP–DFO, or combined DFP–DFO iron chelation treatments. The trial included 265 patients with thalassemia major, with 128 (48.3%) females and 137 (51.7%) males. No deaths occurred with the DFP-alone or the combined DFP–DFO treatments. One death occurred due to graft versus host disease (GVHD) in a patient that had undergone bone marrow transplantation; this patient was censored at the time of transplant. Only one death occurred with the DFP–DFO sequential treatment in a patient that had experienced an episode of heart failure one year earlier. Ten deaths occurred with the deferoxamine treatment. The main factors that correlated with an increase in the hazard ratio for death were: cirrhosis, arrhythmia, previous episode of heart failure, diabetes, hypogonadism, and hypothyroidism. In a Cox regression model, the interaction effect of sex and age was statistically significant (p-value < 0.013). For each increasing year of age, the hazard ratio for males was 1.03 higher than that for females (p-value < 0.013). In conclusion, the results of this study show that the risk factors for predicting mortality in patients with thalassemia major are deferoxamine-treatment, complications, and the interaction effect of sex and age." @default.
• W2034307554 created "2016-06-24" @default.
• W2034307554 creator A5001288323 @default.
• W2034307554 creator A5001394726 @default.
• W2034307554 creator A5003925584 @default.
• W2034307554 creator A5005797043 @default.
• W2034307554 creator A5006539823 @default.
• W2034307554 creator A5010187518 @default.
• W2034307554 creator A5010444302 @default.
• W2034307554 creator A5011385057 @default.
• W2034307554 creator A5012839736 @default.
• W2034307554 creator A5014591808 @default.
• W2034307554 creator A5017086734 @default.
• W2034307554 creator A5021358009 @default.
• W2034307554 creator A5025860412 @default.
• W2034307554 creator A5030315875 @default.
• W2034307554 creator A5043477768 @default.
• W2034307554 creator A5043872690 @default.
• W2034307554 creator A5049806220 @default.
• W2034307554 creator A5059322536 @default.
• W2034307554 creator A5059795117 @default.
• W2034307554 creator A5059999839 @default.
• W2034307554 creator A5064969792 @default.
• W2034307554 creator A5070118055 @default.
• W2034307554 creator A5076597278 @default.
• W2034307554 creator A5081857488 @default.
• W2034307554 creator A5083853152 @default.
• W2034307554 creator A5084125832 @default.
• W2034307554 creator A5085351555 @default.
• W2034307554 creator A5086384100 @default.
• W2034307554 creator A5086986768 @default.
• W2034307554 creator A5090278333 @default.
• W2034307554 date "2009-05-01" @default.
• W2034307554 modified "2023-10-17" @default.
• W2034307554 title "Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies" @default.
• W2034307554 cites W2000650260 @default.
• W2034307554 cites W2016055426 @default.
• W2034307554 cites W2020966580 @default.
• W2034307554 cites W2039403239 @default.
• W2034307554 cites W2069918539 @default.
• W2034307554 cites W2120041716 @default.
• W2034307554 cites W2168793485 @default.
• W2034307554 cites W2317072972 @default.
• W2034307554 doi "https://doi.org/10.1016/j.bcmd.2009.01.002" @default.
• W2034307554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19233692" @default.
• W2034307554 hasPublicationYear "2009" @default.
• W2034307554 type Work @default.
• W2034307554 sameAs 2034307554 @default.
• W2034307554 citedByCount "88" @default.
• W2034307554 countsByYear W20343075542012 @default.
• W2034307554 countsByYear W20343075542013 @default.
• W2034307554 countsByYear W20343075542014 @default.
• W2034307554 countsByYear W20343075542015 @default.
• W2034307554 countsByYear W20343075542016 @default.
• W2034307554 countsByYear W20343075542017 @default.
• W2034307554 countsByYear W20343075542018 @default.
• W2034307554 countsByYear W20343075542019 @default.
• W2034307554 countsByYear W20343075542021 @default.
• W2034307554 countsByYear W20343075542022 @default.
• W2034307554 countsByYear W20343075542023 @default.
• W2034307554 crossrefType "journal-article" @default.
• W2034307554 hasAuthorship W2034307554A5001288323 @default.
• W2034307554 hasAuthorship W2034307554A5001394726 @default.
• W2034307554 hasAuthorship W2034307554A5003925584 @default.
• W2034307554 hasAuthorship W2034307554A5005797043 @default.
• W2034307554 hasAuthorship W2034307554A5006539823 @default.
• W2034307554 hasAuthorship W2034307554A5010187518 @default.
• W2034307554 hasAuthorship W2034307554A5010444302 @default.
• W2034307554 hasAuthorship W2034307554A5011385057 @default.
• W2034307554 hasAuthorship W2034307554A5012839736 @default.
• W2034307554 hasAuthorship W2034307554A5014591808 @default.
• W2034307554 hasAuthorship W2034307554A5017086734 @default.
• W2034307554 hasAuthorship W2034307554A5021358009 @default.
• W2034307554 hasAuthorship W2034307554A5025860412 @default.
• W2034307554 hasAuthorship W2034307554A5030315875 @default.
• W2034307554 hasAuthorship W2034307554A5043477768 @default.
• W2034307554 hasAuthorship W2034307554A5043872690 @default.
• W2034307554 hasAuthorship W2034307554A5049806220 @default.
• W2034307554 hasAuthorship W2034307554A5059322536 @default.
• W2034307554 hasAuthorship W2034307554A5059795117 @default.
• W2034307554 hasAuthorship W2034307554A5059999839 @default.
• W2034307554 hasAuthorship W2034307554A5064969792 @default.
• W2034307554 hasAuthorship W2034307554A5070118055 @default.
• W2034307554 hasAuthorship W2034307554A5076597278 @default.
• W2034307554 hasAuthorship W2034307554A5081857488 @default.
• W2034307554 hasAuthorship W2034307554A5083853152 @default.
• W2034307554 hasAuthorship W2034307554A5084125832 @default.
• W2034307554 hasAuthorship W2034307554A5085351555 @default.
• W2034307554 hasAuthorship W2034307554A5086384100 @default.
• W2034307554 hasAuthorship W2034307554A5086986768 @default.
• W2034307554 hasAuthorship W2034307554A5090278333 @default.
• W2034307554 hasConcept C126322002 @default.
• W2034307554 hasConcept C141071460 @default.
• W2034307554 hasConcept C187212893 @default.
• W2034307554 hasConcept C207103383 @default.
• W2034307554 hasConcept C2776517179 @default.
• W2034307554 hasConcept C2776672577 @default.
• W2034307554 hasConcept C2777218474 @default.

• next